Italia markets open in 1 hour 48 minutes

Onxeo SA (0NWK.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a portafoglio
1,2790+0,5485 (+75,09%)
Alla chiusura: 6:00PM BST
Schermo intero
Chiusura precedente0,7305
Aperto0,5530
Denaro0,0000 x 0
Lettera0,0000 x 0
Min-Max giorno0,5530 - 0,5530
Intervallo di 52 settimane0,5530 - 0,5530
Volume1.000
Media VolumeN/D
Capitalizzazione72,269M
Beta (5 anni mensile)1,49
Rapporto PE (ttm)N/D
EPS (ttm)-0,1230
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector

    Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company’s Board as independent members Paris (France), Oct. 14, 2021 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxeo », a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, today announced the a